Emerging Pharmaceutical Markets Globally

The growth in pharma markets in emerging countries has outpaced the overall growth of the global pharma market. The growth in these markets is being driven by rapidly growing economies of these countries, increasing per capita income, increasing prevalence of lifestyle diseases, and low-cost factors. In 2008, pharma market in E7 countries (Brazil, Russia, China, India, Turkey, Mexico and Indonesia) was estimated at around US$ 96 Billion, and it is expected that high growth in these markets will help these countries increase their share in global pharma market.

According to our new research study on the sector titled “Emerging Pharmaceutical Markets Globally”, the pharmaceutical market in the abovementioned emerging countries is projected to grow at a CAGR of around 14.7% during 2009-2012. Currently, these markets are characterized by rapid urbanization, which has led to the growth in prevalence of lifestyle diseases.

Our report has found that China has the largest pharma market out of these seven countries, followed by Brazil, Mexico and India. However, the maximum growth in future is expected to be in Russia and China due to strong government support. Besides, we have identified that most of the E7 pharmaceutical markets are still dominated by acute therapies, but the growth rate of chronic therapies far exceeds that of acute therapies. Thus, the therapy mix of the market in the next few years will be much different from what it is today.

The research study provides extensive and coherent information about pharma markets in emerging countries. It highlights several emerging opportunities growing in line with development of pharma markets in E7 countries. The research study gives detailed statistical and analytical review on demographics, macroeconomic indicators, disease profile, key drivers and restraints. It contains all the key details that will help clients to draw up market strategies and assess opportunity areas for their success in these emerging pharma markets.
[Fade out the market survey infos]

1. Analyst View
2. Global Pharmaceutical Market
2.1 Market Size
2.2 Mature Markets - G7 Countries
2.3 Emerging Markets - E7 Countries
2.4 E7 Countries to Grow Strongly
3. Why E7 Pharmaceutical Market?
3.1 Economic Growth
3.2 Income Level
3.3 Population Base
3.4 Prevalence of Lifestyle-related Diseases
3.5 Medical & Distribution Infrastructure
3.6 Health Insurance
4. Industry Performance
4.1 Brazil (Past, Present & Future Scenario)
4.1.1 Macroeconomic Indicators
4.1.2 Population Profile
4.1.3 Disease Profile
4.1.4 Healthcare Spending & Financing
4.1.5 Pharmaceutical Market
4.1.6 Import & Export
4.1.7 Generic Drugs
4.1.8 Therapy Areas
4.1.9 Key Players
4.2 Russia (Past, Present & Future Scenario)
4.2.1 Macroeconomic Indicators
4.2.2 Population Profile
4.2.3 Disease Profile
4.2.4 Healthcare Spending & Financing
4.2.5 Pharmaceutical Market
4.2.6 Import
4.2.7 Branded & Generic Drugs
4.2.8 Key Players
4.3 India (Past, Present & Future Scenario)
4.3.1 Macroeconomic Indicators
4.3.2 Population Profile
4.3.3 Disease Profile
4.3.4 Healthcare Spending & Financing
4.3.5 Pharmaceutical Market
4.3.6 Import & Export
4.3.7 Branded & Generic Drugs
4.3.8 Therapy Areas
4.3.9 Key Players
4.4 China (Past, Present & Future Scenario)
4.4.1 Macroeconomic Indicators
4.4.2 Population Profile
4.4.3 Disease Profile
4.4.4 Healthcare Spending & Financing
4.4.5 Pharmaceutical Market
4.4.6 Import & Export
4.4.7 Branded & Generic Drugs
4.4.8 Therapy Areas
4.4.9 Key Players
4.5 Turkey (Past, Present & Future Scenario)
4.5.1 Macroeconomic Indicators
4.5.2 Population Profile
4.5.3 Disease Profile
4.5.4 Healthcare Spending & Financing
4.5.5 Pharmaceutical Market
4.5.6 Import & Export
4.5.7 Branded & Generic Drugs
4.5.8 Therapy Areas
4.5.9 Key Players
4.6 Mexico (Past, Present & Future Scenario)
4.6.1 Macroeconomic Indicators
4.6.2 Population Profile
4.6.3 Disease Profile
4.6.4 Healthcare Spending & Financing
4.6.5 Pharmaceutical Market
4.6.6 Import & Export
4.6.7 Branded & Generic Drugs
4.6.8 Therapy Areas
4.6.9 Key Players
4.7 Indonesia (Past, Present & Future Scenario)
4.7.1 Macroeconomic Indicators
4.7.2 Population Profile
4.7.3 Disease Profile
4.7.4 Healthcare Spending & Financing
4.7.5 Pharmaceutical Market
4.7.6 Import & Export
4.7.7 Branded & Generic Drugs
4.7.8 Key Players
5. Opportunities
5.1 Chronic Diseases
5.2 Pharma Outsourcing Market
5.3 Vaccine Market
5.4 Medical Devices Market
6. Restraining Forces
6.1 Counterfeit Drugs
6.2 Patent Protection
6.3 Traditional Medicines
7. Key Players
7.1 GlaxoSmithKline
7.2 Sanofi-Aventis
7.3 Pfizer Inc.
7.4 Novartis
7.5 AstraZeneca
[Fade out table of contents]

List of Figures:

Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2005-2008
Figure 2-2: Global - Forecast for Pharmaceutical Market (Billion US$), 2009-2012
Figure 2-3: G7 Countries - Pharmaceutical Market (Billion US$), 2008
Figure 2-4: G7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2012
Figure 2-5: G7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2009 to 2012
Figure 2-6: E7 Countries - Pharmaceutical Market (Billion US$), 2008
Figure 2-7: E7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2012
Figure 2-8: E7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2009 to 2012
Figure 2-9: Global - Share of E7 & G7 Countries in Pharmaceutical Market (2008 & 2012)
Figure 3-1: G7 Countries - Real GDP (Trillion US$), 2004 & 2012
Figure 3-2: E7 Countries - Real GDP (Trillion US$), 2004 & 2012
Figure 3-3: Global - Share of E7 & G7 Countries in Population (2007 & 2012)
Figure 3-4: Relative Per Capita Spending on Drugs by Age Group
Figure 4-1: Brazil - Nominal GDP (Billion US$), 2007-2012
Figure 4-2: Brazil - Consumer Price Index (%), 2007-2012
Figure 4-3: Brazil - Currency Exchange Rate (From US$ to BRL), 2007-2012
Figure 4-4: Brazil - Foreign Direct Investment (Billion US$), 2005-2008
Figure 4-5: Brazil - Population (Million), 2006-2012
Figure 4-6: Brazil - Breakup of Population by Age Group (%), 2006-2012
Figure 4-7: Brazil - Population in the Age Group of 65 Years & Above (Million), 2006-2012
Figure 4-8: Brazil - Number of Deaths due to Leading Causes (‘000)
Figure 4-9: Brazil - Breakup of Deaths by Various Causes (%), 2008
Figure 4-10: Brazil - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-11: Brazil - Breakup of Healthcare Payment by Source (%), 2008
Figure 4-12: Brazil - Pharmaceutical Market (Billion US$), 2007-2012
Figure 4-13: Brazil - Pharmaceutical Imports (Billion US$), 2005-2008
Figure 4-14: Brazil - Pharmaceutical Exports (Million US$), 2005-2008
Figure 4-15: Brazil - Generic Drugs Market (Million US$), 2006-2012
Figure 4-16: Brazil - Share of Generic Drugs in Pharmaceutical Market (2008 & 2012)
Figure 4-17: Brazil - Pharmaceutical Market by Segment (%), 2008
Figure 4-18: Russia - Nominal GDP (Billion US$), 2007-2012
Figure 4-19: Russia - Consumer Price Index (%), 2007-2012
Figure 4-20: Russia - Foreign Direct Investment (Billion US$), 2005-2008
Figure 4-21: Russia - Population (Million), 2007-2012
Figure 4-22: Russia - Breakup of Population by Age Group (%), 2007-2012
Figure 4-23: Russia - Population in the Age Group of 65 Years & Above (Million), 2007-2012
Figure 4-24: Russia - Number of Deaths due to Leading Causes ('000)
Figure 4-25: Russia - Breakup of Deaths by Various Causes (%), 2008
Figure 4-26: Russia - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-27: Russia - Breakup of Healthcare Payment by Source (%), 2008
Figure 4-28: Russia - Pharmaceutical Market (Billion Rubles), 2007-2012
Figure 4-29: Russia - Pharmaceutical Imports (Billion Rubles), 2007 & 2008
Figure 4-30: Russia - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
Figure 4-31: India - Nominal GDP (Billion US$), 2007-2012
Figure 4-32: India - Consumer Price Index (%), 2007-2012
Figure 4-33: India - Foreign Direct Investment (Billion US$), 2006-07 to 2008-09
Figure 4-34: India - Foreign Direct Investment in Pharmaceutical Market (Million US$), 2006-07 to 2008-09
Figure 4-35: India - Population (Million), 2006-2012
Figure 4-36: India - Breakup of Population by Age Group (%), 2006-2012
Figure 4-37: India - Population in the Age Group of 65 Years & Above (Million), 2006-2012
Figure 4-38: India - Number of Deaths due to Leading Causes ('000)
Figure 4-39: India - Breakup of Deaths by Various Causes (%), 2008
Figure 4-40: India - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-41: India - Breakup of Healthcare Payment by Source (%), 2006
Figure 4-42: India - Pharmaceutical Market (Billion INR), 2006-07 to 2012-13
Figure 4-43: India - Pharmaceutical Imports (Billion INR), 2006-07 to 2012-13
Figure 4-44: India - Pharmaceutical Exports (Billion INR), 2006-07 to 2012-13
Figure 4-45: India - Forecast for Breakup of Domestic Pharmaceutical Market by Segment (%), 2010
Figure 4-46: China - Nominal GDP (Billion US$), 2007-2012
Figure 4-47: China - Consumer Price Index (%), 2007-2012
Figure 4-48: China - Foreign Direct Investment (Billion US$), 2005-2008
Figure 4-49: China - Population (Million), 2007-2012
Figure 4-50: China - Breakup of Population by Age Group (%), 2007-2012
Figure 4-51: China - Population in the Age Group of 65 Years & Above (Million), 2007-2012
Figure 4-52: China - Number of Deaths due to Leading Causes ('000)
Figure 4-53: China - Breakup of Deaths by Various Causes (%), 2008
Figure 4-54: China - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-55: China - Breakup of Healthcare Payment by Source (%), 2006
Figure 4-56: China - Pharmaceutical Market (Billion US$), 2007-2012
Figure 4-57: China - TCM Market (Billion CNY), 2005-2008
Figure 4-58: China - Pharmaceutical Purchase by Source (%)
Figure 4-59: China - Medicine & Health Product Imports (Billion US$), 2005-2007
Figure 4-60: China - Breakup of Medicine & Health Product Imports by Type (%), 2006
Figure 4-61: China - Medicine & Health Product Exports (Billion US$), 2005-2007
Figure 4-62: China - Breakup of Medicine & Health Product Exports by Type (%), 2006
Figure 4-63: China - Pharmaceutical Market by Type of Drug (%), 2007
Figure 4-64: Turkey - Nominal GDP (Billion US$), 2007-2012
Figure 4-65: Turkey - Consumer Price Index (%), 2007-2012
Figure 4-66: Turkey - Foreign Direct Investment (Billion US$), 2006-2008
Figure 4-67: Turkey - Population (Million), 2006-2012
Figure 4-68: Turkey - Breakup of Population by Age Group (%), 2006-2012
Figure 4-69: Turkey - Population in the Age Group of 65 Years & Above (Million), 2006-2012
Figure 4-70: Turkey - Number of Deaths due to Leading Causes ('000)
Figure 4-71: Turkey - Breakup of Deaths by Various Causes (%), 2008
Figure 4-72: Turkey - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-73: Turkey - Breakup of Healthcare Payment by Source (%)
Figure 4-74: Turkey - Pharmaceutical Market (Billion US$), 2007-2012
Figure 4-75: Turkey - Pharmaceutical Market (Million Boxes), 2006-2008
Figure 4-76: Turkey - Share of Imported & Domestically Manufactured Drugs in Pharmaceutical Market (2008)
Figure 4-77: Turkey - Pharmaceutical Exports (Million US$), 2006-2008
Figure 4-78: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
Figure 4-79: Turkey - Share of Branded & Generic Drugs Sales Volume in Pharmaceutical Market (2008)
Figure 4-80: Mexico - Nominal GDP (Billion US$), 2007-2012
Figure 4-81: Mexico - Consumer Price Index (%), 2007-2012
Figure 4-82: Mexico - Foreign Direct Investment (Billion US$), 2006-2008
Figure 4-83: Mexico - Population (Million), 2006-2012
Figure 4-84: Mexico - Breakup of Population by Age Group (%), 2006-2012
Figure 4-85: Mexico - Population in the Age Group of 65 Years & Above (Million), 2006-2012
Figure 4-86: Mexico - Number of Deaths due to Leading Causes ('000)
Figure 4-87: Mexico - Breakup of Deaths by Various Causes (%), 2008
Figure 4-88: Mexico - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-89: Mexico - Breakup of Healthcare Payment by Source (%)
Figure 4-90: Mexico - Pharmaceutical Market (Billion US$), 2007-2012
Figure 4-91: Mexico - Pharmaceutical Imports (Billion US$), 2003 & 2007
Figure 4-92: Mexico - Pharmaceutical Exports (Billion US$), 2003, 2006 & 2007
Figure 4-93: Mexico - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
Figure 4-94: Mexico - Share of Top Players in Pharmaceutical Market (2007)
Figure 4-95: Indonesia - Nominal GDP (Billion US$), 2007-2012
Figure 4-96: Indonesia - Consumer Price Index (%), 2007-2012
Figure 4-97: Indonesia - Foreign Direct Investment (Billion US$), 2006-2008
Figure 4-98: Indonesia - Population (Million), 2007-2012
Figure 4-99: Indonesia - Breakup of Population by Age Group (%), 2007-2012
Figure 4-100: Indonesia - Population in the Age Group of 65 Years & Above (Million), 2007-2012
Figure 4-101: Indonesia - Number of Deaths due to Leading Causes ('000), 2005
Figure 4-102: Indonesia - Breakup of Deaths by Various Causes (%), 2008
Figure 4-103: Indonesia - Per Head Healthcare Spending (US$), 2006-2012
Figure 4-104: Indonesia - Breakup of Healthcare Payment by Source (%), 2008
Figure 4-105: Indonesia - Pharmaceutical Market (Trillion Rp), 2007-2012
Figure 4-106: Indonesia - Share of OTC & Prescription Drugs in Pharmaceutical Market (2008)
Figure 4-107: Indonesia - Pharmaceutical Exports (Million US$) 2004-2007
Figure 4-108: Indonesia - Pharmaceutical Imports (Million US$) 2004-2007
Figure 4-109: Indonesia - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
Figure 4-110: Indonesia - Share of Top Players in Prescription Pharmaceutical Market (Q1 2009)
Figure 4-111: Indonesia - Share of Top Players in OTC Pharmaceutical Market (Q1 2009)
Figure 5-1: Global - Pharma Outsourcing Market by Segment (%), 2006
Figure 5-2: BRIC Countries - Medical Device Market (Million US$), 2006

List of Tables:

Table 2-1: Global - Pharmaceutical Market by Region (Billion US$), 2008
Table 3-1: E7 Countries - Disposable Income (Million US$), 2007 & 2012
Table 3-2: G7 Countries - Population (Million), 2007 & 2012
Table 3-3: E7 Countries - Population (Million), 2007 & 2012
Table 3-4: G7 Countries - Population in the Age Group of 65 Years & Above (Million), 2007 & 2012
Table 3-5: E7 Countries - Population in the Age Group of 65 Years & Above (Million), 2007 & 2012
Table 4-1: Brazil - Performance of Top 10 Players in Pharmaceutical Market (2006)
Table 4-2: Russia - Performance of Key Players in Pharmaceutical Market (2008)
Table 4-3: India - Performance of Drugs by Therapeutic Segment in Domestic Pharmaceutical Market
Table 4-4: India - Performance of Top 10 Pharmaceutical Players (2008)
Table 4-5: China - Performance of Drugs by Key Therapeutic Segment in Pharmaceutical Market (2005 & 2006)
Table 4-6: China - Performance of Key Players in Pharmaceutical Market (H1 2006 & H1 2007)
Table 4-7: Turkey - Performance of Key Therapy Areas in Pharmaceutical Market (2008)
Table 4-8: Turkey - Top 20 Pharmaceutical Players by Sales (Million US$), Jan-Sep 2007
Table 4-9: Turkey - Top 20 Pharmaceutical Players by Sales Volume (Million Units), Jan-Sep 2007
Table 4-10: Mexico - Performance of Therapy Areas in Retail Pharmaceutical Market (2006)
Table 5-1: India - Market for Various Chronic Diseases (Billion INR), 2006 & 2010
Table 5-2: India, China & Brazil - Vaccine Market (Million US$), 2006 & 2010
Table 7-1: GlaxoSmithKline plc - Strengths & Weaknesses
Table 7-2: Sanofi-Aventis - Strengths & Weaknesses
Table 7-3: Pfizer Inc - Strengths & Weaknesses
Table 7-4: Novartis - Strengths & Weaknesses
Table 7-5: AstraZeneca - Strengths & Weaknesses
[Fade out list of tables / figures]